![Sailaja Puttagunta](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sailaja Puttagunta
Plus aucun poste en cours
Fortune : 311 $ au 31/03/2026
Profil
Sailaja Puttagunta formerly worked at Durata Therapeutics, Inc., as Vice President-Development & Medical Affairs in 2014, Allergan UC, as Vice President-Medical Affairs from 2015 to 2016, Iterum Therapeutics Plc, as Vice President-Development from 2016 to 2018, BiomX Ltd., as Chief Medical Officer from 2018 to 2019, BiomX, Inc., as Chief Medical Officer from 2019 to 2021, and Iterum Therapeutics Plc, as Chief Medical Officer from 2021 to 2024.
Dr. Puttagunta received her graduate degree from New York University School of Medicine and undergraduate degree from Gandhi Medical College & Hospital.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/11/2025 | 10 369 ( 0,02% ) | 311 $ | 31/03/2026 |
Anciens postes connus de Sailaja Puttagunta
| Sociétés | Poste | Fin |
|---|---|---|
| ITERUM THERAPEUTICS PLC | Directeur Technique/Scientifique/R&D | 31/05/2024 |
| BIOMX INC. | Directeur Technique/Scientifique/R&D | 13/12/2021 |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer treatment | Directeur Technique/Scientifique/R&D | 01/10/2019 |
| ITERUM THERAPEUTICS PLC | Corporate Officer/Principal | 01/12/2018 |
| ALLERGAN PLC | Directeur Technique/Scientifique/R&D | 01/01/2016 |
Formation de Sailaja Puttagunta
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
34
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics for infectious diseases and acute illnesses | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gandhi Medical College & Hospital
 Gandhi Medical College & Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iterum Therapeutics Plc
 Iterum Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem | Health Technology |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer treatment | Health Technology |
BiomX, Inc.
 BiomX, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company developing natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin | Health Technology |
